Evaxion Biotech A/S

1.81
-0.13 (-6.70%)
At close: Mar 03, 2025, 3:59 PM
1.89
4.25%
After-hours: Mar 03, 2025, 04:00 PM EST

Evaxion Biotech A/S Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 73K n/a n/a n/a n/a n/a
Cost of Revenue 112.00 571.32K 343.45K 105.72K 80.98K 73.93K
Gross Profit 72.89K -571.32K -343.45K -105.72K -80.98K -73.93K
Operating Income -22.2M -25.26M -25.83M -16.57M -10.86M -5.63M
Interest Income 154K 2.83M 2.04M 216K 9K 2K
Pretax Income -22.91M -23.94M -24.71M -16.57M -12.02M -6.27M
Net Income -22.13M -23.17M -24.53M -15.02M -11.2M -5.54M
Selling & General & Admin 10.35M 8.21M 6.25M 5.67M 2.63M 1.88M
Research & Development 11.92M 17.06M 19.58M 10.9M 8.22M 3.73M
Other Expenses n/a n/a n/a n/a 16K 15K
Operating Expenses 22.25M 25.26M 25.83M 16.57M 10.86M 5.63M
Interest Expense 897K 1.51M 915K 223K 1.22M 698K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 22.27M 25.26M 25.83M 16.57M 10.86M 5.63M
Income Tax -791.22K -772K -178K -1.56M -825K -735K
Shares Outstanding (Basic) 13.67M 11.82M 9.75M 8.1M 8.1M 9.6M
Shares Outstanding (Diluted) 13.67M 11.82M 9.75M 8.1M 8.1M 9.6M
EPS (Basic) -1.62 -1.96 -2.52 -1.85 -1.38 -0.58
EPS (Diluted) -1.62 -1.96 -2.52 -1.85 -1.38 -0.58
EBITDA -21.4M -22.58M -24.17M -16.46M -11.9M -6.18M
Depreciation & Amortization 615.95K 571.32K 343.45K 105.72K 80.98K 73.93K